\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\ \(415\)\
\-\ n\\/a\\ \ \(1\)\
\-\ lab\ \(1091\)\
\-\ hbv\\ e\\ ag\\ \\(\\-\\)\ \(0\)\
\-\ hbv\\ e\\ ab\\ \\(\\+\\)\ \(0\)\
\-\ ferritin\\ 760\\ \\(150\\)\ \(0\)\
\-\ afp\\ 2483\\ \\(15\\)\ \(0\)\
\-\ currently\\ not\\ determined\\.\ \(0\)\
\-\ ct\\ findings\ \(1\)\
\-\ increased\\ portal\\ venous\\ diameter\\ \\(\\>13mm\\)\ \(0\)\
\-\ portal\\ vein\\ thrombosis\ \(7\)\
\-\ ascites\\ \\(not\\ seen\\ on\\ these\\ images\\)\ \(0\)\
\-\ enlarged\\ splenic\\ and\\ mesenteric\\ veins\\ \\(\\>10mm\\,\\ 10mm\\ on\\ these\\ images\\)\ \(0\)\
\-\ porto\\-systemic\\ collaterals\ \(0\)\
\-\ hepatocellular\\ carcinoma\\ \\(hepatoma\\)\\ with\\ portal\\ vein\\ invasion\\ and\\ thrombosis\ \(0\)\
\-\ differential\\ for\\ portal\\ hypertension\ \(0\)\
\-\ prehepatic\ \(0\)\
\-\ \\ \\ portal\\/splenic\\ vein\\ occlusion\ \(0\)\
\-\ intraheptic\ \(0\)\
\-\ \\ \\ cirrhosis\ \(1\)\
\-\ \\ \\ metastatic\ \(0\)\
\-\ \\ \\ parasitic\ \(0\)\
\-\ posthepatic\ \(0\)\
\-\ \\ \\ cardiac\\ \\(chf\\,\\ tricuspid\\ insufficiency\\,\\ conststrictive\\ pericarditis\\)\ \(0\)\
\-\ \\ \\ hepatic\\ vein\\ occlusion\\ \\(budd\\-chiari\\)\ \(0\)\
\-\ 62\\ y\\/o\\ female\\ with\\ liver\\ mass\\ possibly\\ hemangioma\\ on\\ ct\\ scan\\ for\\ 3\\-phase\\ ct\\ scan\\ of\\ liver\\ to\\ evaluate\\.\\ pt\\ with\\ history\\ of\\ chronic\\ hepatitis\\ b\\ and\\ is\\ at\\ risk\\ for\\ hcc\\ \\(hepatocellular\\ carcinoma\\)\\.\ \(0\)\
\-\ originally\\ suspected\\ hemangioma\\ in\\ this\\ patient\\ with\\ known\\ hepatitis\\ b\\ infection\\ and\\ vague\\ history\\ of\\ findings\\ of\\ mass\\ discovered\\ in\\ ct\\ performed\\ at\\ another\\ institution\\.\\ \\ spect\\ imaging\\ with\\ tc99m\\-rbc\\ for\\ hemagioma\\ not\\ consistent\\ with\\ hemangioma\\.\\ \\ laboratory\\ findings\\ were\\ more\\ consistent\\ with\\ hcc\\ with\\ marked\\ elevation\\ of\\ alpha\\ feto\\-protein\\.\\ \\ follow\\-up\\ imaging\\ revealed\\ diffuse\\ involvement\\ of\\ the\\ liver\\ and\\ portal\\ vein\\ invasion\\/thrombosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ portal\\:\\ 0\\.40502053447880787\ \(0\)\
\-\ vein\\:\\ 0\\.25280399797726577\ \(0\)\
\-\ hbv\\:\\ 0\\.21558363876352743\ \(0\)\
\-\ hemangioma\\:\\ 0\\.17800514889377722\ \(0\)\
\-\ 10mm\\:\\ 0\\.17268478964341077\ \(0\)\
\-\ thrombosis\\:\\ 0\\.17253313257585493\ \(0\)\
\-\ hcc\\:\\ 0\\.16314687513318268\ \(0\)\
\-\ liver\\:\\ 0\\.14598115712214196\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.1450345030259307\ \(0\)\
\-\ hepatitis\\:\\ 0\\.1450345030259307\ \(0\)\
\-\ splenic\\:\\ 0\\.13839999980714232\ \(0\)\
\-\ occlusion\\:\\ 0\\.12961537951528565\ \(0\)\
\-\ invasion\\:\\ 0\\.125839490695251\ \(0\)\
\-\ 2483\\:\\ 0\\.11280564848159443\ \(0\)\
\-\ intraheptic\\:\\ 0\\.11280564848159443\ \(0\)\
\-\ conststrictive\\:\\ 0\\.11280564848159443\ \(0\)\
\-\ with\\:\\ 0\\.11049780773696104\ \(0\)\
\-\ 760\\:\\ 0\\.10779181938176371\ \(0\)\
\-\ prehepatic\\:\\ 0\\.10779181938176371\ \(0\)\
\-\ posthepatic\\:\\ 0\\.10779181938176371\ \(0\)\
\-\ hemagioma\\:\\ 0\\.10779181938176371\ \(0\)\
\-\ ct\\:\\ 0\\.10741794433612299\ \(0\)\
\-\ findings\\:\\ 0\\.10444002494969601\ \(0\)\
\-\ ferritin\\:\\ 0\\.0956632535634602\ \(0\)\
\-\ 13mm\\:\\ 0\\.0956632535634602\ \(0\)\
\-\ hepatoma\\:\\ 0\\.0956632535634602\ \(0\)\
\-\ ag\\:\\ 0\\.08789011519472861\ \(0\)\
\-\ tricuspid\\:\\ 0\\.08789011519472861\ \(0\)\
\-\ collaterals\\:\\ 0\\.08563559536379876\ \(0\)\
\-\ for\\:\\ 0\\.08551812875502536\ \(0\)\
\-\ carcinoma\\:\\ 0\\.08438530942624968\ \(0\)\
\-\ pericarditis\\:\\ 0\\.08433274683549222\ \(0\)\
\-\ scan\\:\\ 0\\.08369884704055901\ \(0\)\
\-\ not\\:\\ 0\\.08354019588059164\ \(0\)\
\-\ of\\:\\ 0\\.08282386856099143\ \(0\)\
\-\ ab\\:\\ 0\\.08157343756659134\ \(0\)\
\-\ spect\\:\\ 0\\.08062176626396805\ \(0\)\
\-\ these\\:\\ 0\\.07966561628795464\ \(0\)\
\-\ chf\\:\\ 0\\.07741274837898675\ \(0\)\
\-\ 150\\:\\ 0\\.07672559249005406\ \(0\)\
\-\ parasitic\\:\\ 0\\.07672559249005406\ \(0\)\
\-\ consistent\\:\\ 0\\.0764946662891944\ \(0\)\
\-\ afp\\:\\ 0\\.07430508863583077\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.07430508863583077\ \(0\)\
\-\ alpha\\:\\ 0\\.07430508863583077\ \(0\)\
\-\ imaging\\:\\ 0\\.07414023226026324\ \(0\)\
\-\ and\\:\\ 0\\.07287909011697268\ \(0\)\
\-\ ascites\\:\\ 0\\.07275736826280756\ \(0\)\
\-\ originally\\:\\ 0\\.071823670254146\ \(0\)\
\-\ institution\\:\\ 0\\.06975794224406448\ \(0\)\
\-\ vague\\:\\ 0\\.06901947663807517\ \(0\)\
\-\ insufficiency\\:\\ 0\\.0679884110076935\ \(0\)\
\-\ determined\\:\\ 0\\.06719035191735798\ \(0\)\
\-\ 62\\:\\ 0\\.06719035191735798\ \(0\)\
\-\ possibly\\:\\ 0\\.06629606180386637\ \(0\)\
\-\ images\\:\\ 0\\.0652570598951705\ \(0\)\
\-\ discovered\\:\\ 0\\.06430800059776788\ \(0\)\
\-\ elevation\\:\\ 0\\.06430800059776788\ \(0\)\
\-\ on\\:\\ 0\\.06391107747096571\ \(0\)\
\-\ lab\\:\\ 0\\.06371051123570379\ \(0\)\
\-\ veins\\:\\ 0\\.06259573666089353\ \(0\)\
\-\ mesenteric\\:\\ 0\\.0609046270564929\ \(0\)\
\-\ suspected\\:\\ 0\\.05779696731333693\ \(0\)\
\-\ another\\:\\ 0\\.05772486434479925\ \(0\)\
\-\ diameter\\:\\ 0\\.05669092332222495\ \(0\)\
\-\ hepatic\\:\\ 0\\.056172915685166636\ \(0\)\
\-\ evaluate\\:\\ 0\\.054851057738714196\ \(0\)\
\-\ currently\\:\\ 0\\.05418548235101572\ \(0\)\
\-\ hypertension\\:\\ 0\\.053971353639969966\ \(0\)\
\-\ history\\:\\ 0\\.05389921347642604\ \(0\)\
\-\ mass\\:\\ 0\\.05388728042522354\ \(0\)\
\-\ marked\\:\\ 0\\.053350355004347046\ \(0\)\
\-\ at\\:\\ 0\\.05328620549488522\ \(0\)\
\-\ cardiac\\:\\ 0\\.052380004507735785\ \(0\)\
\-\ laboratory\\:\\ 0\\.05122266319874498\ \(0\)\
\-\ involvement\\:\\ 0\\.0510538465963374\ \(0\)\
\-\ pt\\:\\ 0\\.05076385217219195\ \(0\)\
\-\ risk\\:\\ 0\\.0504007245566009\ \(0\)\
\-\ venous\\:\\ 0\\.05036102749500041\ \(0\)\
\-\ enlarged\\:\\ 0\\.04808670682065839\ \(0\)\
\-\ 15\\:\\ 0\\.04766529483950859\ \(0\)\
\-\ revealed\\:\\ 0\\.04625140083309482\ \(0\)\
\-\ differential\\:\\ 0\\.045832186989728546\ \(0\)\
\-\ known\\:\\ 0\\.04566840149503342\ \(0\)\
\-\ diffuse\\:\\ 0\\.04423606880905751\ \(0\)\
\-\ infection\\:\\ 0\\.04260904503231657\ \(0\)\
\-\ chronic\\:\\ 0\\.04186935200818455\ \(0\)\
\-\ performed\\:\\ 0\\.041730522372754326\ \(0\)\
\-\ more\\:\\ 0\\.038732916970043496\ \(0\)\
\-\ metastatic\\:\\ 0\\.038686574789375504\ \(0\)\
\-\ physical\\:\\ 0\\.0382473331445972\ \(0\)\
\-\ increased\\:\\ 0\\.03814360651064507\ \(0\)\
\-\ were\\:\\ 0\\.03636031056449932\ \(0\)\
\-\ exam\\:\\ 0\\.03550887402359191\ \(0\)\
\-\ in\\:\\ 0\\.03509513973445314\ \(0\)\
\-\ female\\:\\ 0\\.03403784757324946\ \(0\)\
\-\ seen\\:\\ 0\\.03320872819182031\ \(0\)\
\-\ this\\:\\ 0\\.02423813359886631\ \(0\)\
\-\ patient\\:\\ 0\\.022942476477606687\ \(0\)\
\-\ is\\:\\ 0\\.01931731572681646\ \(0\)\
\-\ to\\:\\ 0\\.01763436618104766\ \(0\)\
\-\ the\\:\\ 0\\.014074890703450766\ \(0\)\
